| Literature DB >> 28049432 |
Helga Ertesvåg1, Håvard Sletta2, Mona Senneset3,2, Yi-Qian Sun3, Geir Klinkenberg2, Therese Aursand Konradsen3, Trond E Ellingsen2, Svein Valla3.
Abstract
BACKGROUND: Polysaccharides often are necessary components of bacterial biofilms and capsules. Production of these biopolymers constitutes a drain on key components in the central carbon metabolism, but so far little is known concerning if and how the cells divide their resources between cell growth and production of exopolysaccharides. Alginate is an industrially important linear polysaccharide synthesized from fructose 6-phosphate by several bacterial species. The aim of this study was to identify genes that are necessary for obtaining a normal level of alginate production in alginate-producing Pseudomonas fluorescens.Entities:
Keywords: Alginate biosynthesis; Fructose 6-phosphate; Peptidoglycan recycling; Pseudomonas fluorescens; Purine; Transposon mutants; Tryptophan
Mesh:
Substances:
Year: 2017 PMID: 28049432 PMCID: PMC5210274 DOI: 10.1186/s12864-016-3467-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1The relationship between alginate biosynthesis and the cellular metabolism in P. fluorescens. a The proteins and metabolites needed for alginate biosynthesis. b A simplified model of the cell’s metabolism highlighting the processes identified in the present study as being important for full alginate biosynthesis levels. The genes discussed in the paper are highlighted in yellow. The Entner-Doudoroff pathway and the oxidative part of the pentose phosphate pathway are indicated by red arrows, and the non-oxidative part of the pentose phosphate pathway with purple arrows. Green arrows indicate other pathways competing with accumulation of the three metabolites Fru6P, GTP and c-di-GMP, while blue arrows indicate pathways that would increase the synthesis of one of these three metabolites. Each arrow may represent several enzymatic steps. Abbreviations: OM: Outer membrane, IM: Inner membrane, M: mannuronic acid residue, G: guluronic acid residue, Ac: Acetyl, TCA: Tricarboxylic acid cycle, PP: the non-oxidative part of the pentose phosphate pathway, GN6P: Glucosamine 6-phosphate, PG: Peptidoglycan, G6P: Glucose 6-phosphate, 6PG: 6-phosphogluconate, Pyr: Pyruvate, ILV: Isoleucine Leucine Valine, B5: Pantothenate, Trp: Tryptophan, PRPP: Phosphoribosyl pyrophosphate, R5P: Ribose 5-phosphate, E4P: Erythrose 4-phosphate
Fig. 2Genotypes for selected genetic constructs used in this study. a Strain MS1 in which the Pm promoter and the gene encoding XylS is inserted between the promoter and start codon of algD. b Strain MS2 in which a transposon expressing algC from PmG5 is inserted into PFLU2944 in an algC − derivative of MS1. c Map of the transposon TnMS11 used for mutagenesis in this study. d Strain HE230 in which the gene encoding XylS and the PmG5 promoter is inserted between the promoter and start codon of algC in SBW25mucA. Inactivation of mucA confers a high level expression from wild type PalgD. Relevant promoters, and the two restriction sites used for sequencing are displayed above each map-line. The alg-genes are coloured to match Fig. 1, other P. fluorescens genes flanking the genes of interest are coloured blue, and heterologous genes and elements are coloured green. I and O denote the minitransposon ends
Identified mutants and their growth yield and alginate production in the three mediaa
| Number of independent transposon mutants | Gene ID | Gene | Function | Growth (G) and Alginate production (A) in different mediaa | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIA Gly | 0.5xDEF4 Gly | 0.5xDEF4 Fru | |||||||||||||
| G | A | G | A | G | A | ||||||||||
| % | SD | % | SD | % | SD | % | SD | % | SD | % | SD | ||||
| SBW25 WT |
| 6 |
|
| 86 | 0 |
| 0 |
| 6 |
| 6 | |||
| Control | 100 | 6 | 100 | 13 | 100 | 2 | 100 | 13 | 100 | 5 | 100 | 3 | |||
| 1 | PFLU0460 |
| Energy production and conversion | 66 | 2 | 63 | 2 | 57 | 4 |
| 4 |
| 20 |
| 4 |
| 1 | PFLU3193 |
| 108 | 4 |
| 2 | 98 | 6 | 89 | 9 |
| 3 | 106 | 19 | |
| 1 | PFLU5345 |
|
| 18 | 69 | 3 | 102 | 1 | 65 | 5 |
| 7 |
| 13 | |
| 2 | PFLU3801 |
| Cell cycle control, cell division, chromosome partitioning |
| 0 |
| 5 | 72 | 14 |
| 3 |
| 42 |
| 3 |
| PFLU3801 |
| 53 | 7 |
| 8 | 102 | 2 | 86 | 8 |
| 1 |
| 4 | ||
| 1 | PFLU5304 | 107 | 6 |
| 7 | 100 | 6 | 96 | 8 |
| 18 | 101 | 12 | ||
| 1 | PFLU1384 | Amino acid transport and metabolism | 108 | 3 |
| 3 | 71 | 1 | 81 | 33 |
| 45 | 95 | 6 | |
| 1 | PFLU2019 |
| 27 |
| 3 | 116 | 14 |
| 1 |
| 14 |
| 0 | ||
| 1 | PFLU2124 |
| 4 |
| 7 | 102 | 2 | 88 | 7 |
| 30 | 55 | 27 | ||
| 1 | PFLU3475 | 106 | 2 |
| 11 | 98 | 7 | 88 | 9 |
| 5 | 99 | 32 | ||
| 1 | PFLU3887 | 104 | 4 |
| 11 | 93 | 6 | 72 | 16 |
| 28 | 53 | 5 | ||
| 1 | PFLU5797 |
| 69 | 22 | 64 | 2 | 60 | 10 |
| 1 |
| 31 |
| 3 | |
| 1 | PFLU4188 |
| 100 | 2 |
| 3 | 105 | 5 |
| 0 |
| 3 |
| 5 | |
| 1 | PFLU5559 |
| 62 | 5 | 58 | 11 | 106 | 9 |
| 12 |
| 23 |
| 1 | |
| 2 | PFLU5561 |
| 102 | 2 | 55 | 4 |
| 1 |
| 3 |
| 14 |
| 2 | |
| 1 | PFLU0612 |
| Nucleotide transport and metabolism |
| 5 |
| 2 | 81 | 3 |
| 0 |
| 13 |
| 0 |
| 1 | PFLU4183 |
| 55 | 2 |
| 21 | 81 | 2 |
| 6 |
| 11 |
| 2 | |
| 4 | PFLU5034 |
| 50 | 1 |
| 10 | 70 | 1 |
| 3 |
| 7 |
| 2 | |
| 2 | PFLU6054 |
| 84 | 4 |
| 5 | 113 | 8 |
| 4 |
| 3 |
| 4 | |
| 1 | PFLU6055 |
| 88 | 7 |
| 25 | 87 | 5 |
| 5 |
| 9 |
| 2 | |
| 2 | PFLU5396 |
| 79 | 2 |
| 17 | 106 | 2 | 66 | 9 |
| 16 | 62 | 18 | |
| 2 | PFLU1142 |
| Carbohydrate transport and metabolism | 52 | 2 | 66 | 39 |
| 7 |
| 4 |
| 9 | 52 | 40 |
| 3 | PFLU1143 |
| 59 | 2 |
| 2 |
| 3 |
| 2 |
| 10 | 80 | 4 | |
| 1 | PFLU3030 |
| 109 | 5 |
| 7 | 94 | 4 | 84 | 18 | 122 | 7 |
| 16 | |
| 2 | PFLU3365 |
| 107 | 2 | 62 | 12 | 97 | 1 | 98 | 3 |
| 17 |
| 4 | |
| 3 | PFLU4630 |
|
| 8 | 73 | 14 | 92 | 7 | 68 | 23 | 125 | 3 |
| 20 | |
| 1 | PFLU4949 |
| 107 | 4 |
| 14 | 51 | 3 |
| 5 |
| 3 | 85 | 12 | |
| 1 | PFLU0416 |
| Coenzyme transport and metabolism |
| 5 | 68 | 8 | 98 | 2 | 66 | 14 | 117 | 11 |
| 12 |
| 1 | PFLU5820 |
| Translation, ribosomal structure and biogenesis | 77 | 3 |
| 12 | 78 | 0 |
| 5 | 65 | 23 |
| 3 |
| 1 |
|
| 10 | 52 | 16 | 98 | 1 | 94 | 14 |
| 15 |
| 24 | ||
| 1 | PFLU3173 | Transcription | 92 | 8 |
| 3 | 93 | 2 | 89 | 4 |
| 0 | 67 | 7 | |
| 1 | PFLU3307 |
| 18 | 74 | 11 | 103 | 2 | 88 | 28 |
| 10 |
| 8 | ||
| 1 | PFLU4259 | 125 | 2 | 62 | 1 | 75 | 5 | 84 | 11 |
| 20 |
| 5 | ||
| 1 | PFLU4774 | 102 | 10 |
| 3 | 91 | 12 | 75 | 7 | 110 | 3 | 79 | 26 | ||
| 1 | PFLU5984 |
| Replication, recombination and repair | 114 | 6 |
| 6 |
| 3 | 62 | 7 |
| 5 | 86 | 1 |
| 1 | PFLU0013 |
| Cell wall/ membrane/ envelope biogenesis | 117 | 7 |
| 5 | 78 | 5 | 62 | 3 | 123 | 24 |
| 18 |
| 1 | PFLU1562 |
| 67 | 1 |
| 2 | 89 | 2 | 60 | 20 |
| 9 | 80 | 7 | |
| 1 | PFLU4993 |
| 58 | 2 |
| 2 | 87 | 1 | 53 | 10 |
| 6 | 83 | 17 | |
| 1 | PFLU5439 |
|
| 6 |
| 5 | 103 | 1 | 80 | 8 | 106 | 4 |
| 6 | |
| 2 | PFLU5545 | 62 | 3 |
| 2 | 99 | 9 | 90 | 11 |
| 1 | 65 | 6 | ||
| 2 | PFLU5546 |
| 54 | 4 |
| 2 | 86 | 4 | 68 | 11 |
| 1 | 59 | 26 | |
| 3 | PFLU5573 |
| 95 | 30 |
| 10 |
| 2 |
| 4 |
| 18 |
| 38 | |
| 1 | PFLU5461 |
| 88 | 5 |
| 6 | 85 | 4 |
| 8 |
| 31 |
| 7 | |
| 1 | PFLU4418 |
| Cell motility | 88 | 1 |
| 4 | 80 | 4 | 104 | 29 | 80 | 1 |
| 12 |
| 1 | PFLU4439 |
|
| 8 |
| 2 | 97 | 3 |
| 0 |
| 3 |
| 0 | |
| 1 | PFLU4448 |
| 111 | 8 |
| 2 | 87 | 5 | 102 | 7 |
| 3 |
| 6 | |
| 1 | PFLU0870 |
| Posttransla-tional modification, protein turnover, chaperones | 111 | 3 |
| 5 | 103 | 1 | 88 | 6 |
| 6 |
| 16 |
| 4 | PFLU2032 |
| 100 | 2 |
| 6 | 81 | 3 | 59 | 6 | 124 | 7 |
| 6 | |
| 2 | PFLU2614 |
| 98 | 3 |
| 3 | 96 | 1 | 73 | 8 | 108 | 7 | 109 | 12 | |
| 1 | PFLU3805 |
|
| 7 | 60 | 7 | 104 | 1 |
| 20 |
| 8 |
| 21 | |
| 3 | PFLU4383 | 118 | 6 |
| 8 | 87 | 22 | 51 | 5 |
| 8 |
| 13 | ||
| 1 | PFLU5007 |
| 102 | 7 |
| 6 | 97 | 2 | 79 | 5 | 120 | 10 | 84 | 2 | |
| 2 | PFLU5911 |
| Inorganic ion transport and metabolism | 50 | 2 | 82 | 38 | 73 | 3 | 67 | 28 | 90 | 13 | 76 | 2 |
| PFLU5911 |
| 54 | 1 |
| 0 | 73 | 4 | 101 | 7 | 107 | 5 | 98 | 15 | ||
| 1 | PFLU0511 |
| General function prediction only | 108 | 5 | 86 | 11 | 96 | 4 | 101 | 32 | 104 | 12 |
| 26 |
| 1 | PFLU2104 |
| 9 | 66 | 18 | 94 | 1 | 65 | 13 | 117 | 7 |
| 15 | ||
| 1 | PFLU2996 |
| 10 | 66 | 7 | 104 | 3 | 74 | 12 | 122 | 9 |
| 5 | ||
| 1 | PFLU3202 | 108 | 3 | 76 | 10 | 81 | 3 |
| 6 |
| 7 |
| 3 | ||
| 1 | PFLU3391 | 51 | 25 | 58 | 8 | 68 | 1 | 95 | 7 | 118 | 0 |
| 13 | ||
| 1 | PFLU3411 | 105 | 6 | 50 | 9 | 101 | 2 | 70 | 29 |
| 2 |
| 19 | ||
| 1 | PFLU3456 | 104 | 4 |
| 5 | 103 | 0 | 107 | 2 |
| 13 |
| 6 | ||
| 1 | PFLU1883 | Function unknown | 69 | 0 |
| 0 | 74 | 14 | 66 | 14 |
| 268 |
| 0 | |
| 1 | PFLU1995 |
| 7 | 85 | 9 | 104 | 1 | 97 | 7 |
| 18 |
| 17 | ||
| 1 | PFLU4517 |
| 3 | 82 | 6 | 96 | 3 |
| 5 |
| 18 |
| 6 | ||
| 1 | PFLU5579 |
|
| 2 |
| 21 | 104 | 5 |
| 3 |
| 32 |
| 7 | |
| 1 | PFLU2489 | 93 | 10 |
| 51 | 69 | 3 | 75 | 8 |
| 40 |
| 9 | ||
| 1 | PFLU5377 | 107 | 8 |
| 3 | 97 | 4 | 76 | 5 |
| 1 | 92 | 20 | ||
| 1 | Upstream PFLU2629 | 107 | 6 |
| 3 | 106 | 4 | 84 | 13 |
| 16 | 106 | 7 | ||
| 1 | Upstream PFLU3162 | 122 | 2 | 77 | 20 | 76 | 1 | 88 | 12 |
| 36 | 96 | 15 | ||
| 1 | Upstream PFLU3931 | 97 | 2 |
| 3 | 75 | 2 |
| 3 |
| 11 |
| 5 | ||
| 1 | PFLU2519 | Pseudogene | 114 | 4 |
| 26 | 102 | 3 | 98 | 6 |
| 9 | 89 | 13 | |
| 1 | PFLU0259 |
| Signal transduction mechanisms | 89 | 5 |
| 1 | 101 | 4 | 70 | 12 |
| 17 | 101 | 12 |
| 2 | PFLU0461 |
| 85 | 14 |
| 4 | 120 | 4 | 104 | 13 |
| 11 | 67 | 1 | |
| 1 | PFLU4125A | 119 | 4 |
| 14 | 112 | 0 | 86 | 4 |
| 5 | 72 | 2 | ||
| 4 | PFLU5236 |
|
| 1 |
| 7 | 105 | 4 | 55 | 7 |
| 5 | 66 | 21 | |
| 2 | PFLU5237 |
| 118 | 1 |
| 3 | 109 | 3 |
| 3 |
| 24 |
| 2 | |
| 2 | PFLU5819 |
| 80 | 12 |
| 3 | 90 | 6 | 79 | 15 |
| 1 |
| 5 | |
| 1 | PFLU6039 |
| 78 | 1 |
| 20 | 102 | 2 | 90 | 16 | 110 | 7 | 84 | 21 | |
| 1 | PFLU6040 |
|
| 0 |
| 0 | 97 | 12 | 87 | 0 | 99 | 22 | 100 | 23 | |
| 1 | PFLU2808 | 100 | 2 |
| 3 | 110 | 4 | 75 | 5 |
| 52 |
| 11 | ||
| 1 | PFLU3002 | Intracellular trafficking, secretion, and vesicular transport |
| 6 |
| 15 | 93 | 5 | 83 | 6 |
| 9 | 94 | 5 | |
| 1 | PFLU3951 | 106 | 6 |
| 1 | 105 | 2 | 83 | 1 | 110 | 5 | 101 | 20 | ||
| 1 | PFLU5567 | 98 | 9 | 61 | 5 |
| 0 |
| 0 | 59 | 1 |
| 4 | ||
a: The strains were cultivated in microtiter plates for three days before cell and alginate yield were measured. The mutants shown are those that displayed significantly different alginate production levels in at least one of the three tested media. Data are not shown for strains with transposon insertions in the genes encoded by the alginate operon or in algC. The Table shows how many independent transposon insertions mutants that were identified for each gene, the gene identifier, the gene name, and which functional group the corresponding protein is assigned to. Growth above 125% and alginate production above 110% are marked using bold types, growth and alginate production between 10 and 50% are marked using italics, and growth and alginate production below 10% are written in bold italics. Three biological replicates were cultivated for each strain, and the results are given as percent (%) of the values obtained from the control strain MS2. Standard deviations for the three replicates are shown in the columns to the right (SD)
Growth and alginate production of mutants using medium supplements or complementing transposonsa
| Inactivated gene | Supplement/comple-menting gene (s)b | PIA | 0.5xDEF4 Glycerol | 0.5xDEF4 Fructose | |||
|---|---|---|---|---|---|---|---|
| Growthc | Alginate | Growthc | Alginate | Growth | Alginate | ||
| wt | 100 | 100 | 100 | 100 | 100 | 100 | |
|
| 65 |
|
|
|
|
| |
| tryptophane | 70 |
| 78 | 60 |
|
| |
|
| 88 |
| 88 | 94 |
| 106 | |
|
| 56 |
|
|
|
|
| |
| tryptophane | 68 |
| 68 | 80 | 71 | 75 | |
|
| 85 |
| 114 |
|
|
| |
|
| 89 | 85 | 81 | 91 |
|
| |
|
|
|
|
|
|
|
| |
| Adenine, thiamine | 51 |
|
|
|
|
| |
|
| 90 | 100 | 91 | 88 |
| 97 | |
|
|
|
|
|
|
|
| |
| Adenine, thiamine | 56 | 91 |
|
|
|
| |
|
| 57 |
|
|
|
|
| |
|
|
|
|
|
|
|
| |
| Adenine, thiamine | 52 |
|
|
|
|
| |
|
| 77 |
|
|
|
|
| |
|
| 91 | 82 | 91 | 109 |
| 97 | |
|
|
| 58 |
|
|
|
| |
|
| 96 |
| 85 | 96 |
|
| |
| PFLU3030 | 88 |
| 80 | 89 | 104 | 103 | |
| PFLU3030 | 97 |
| 89 |
| 101 |
| |
|
| 108 | 52 | 111 | 89 |
|
| |
|
| 105 |
| 105 |
| 94 | 92 | |
|
| 100 |
| 100 |
|
|
| |
|
| 91 | 109 | 104 | 106 | 109 | 100 | |
|
| 53 |
|
| 93 | 115 | 75 | |
|
| 87 |
| 84 |
|
| 79 | |
|
|
|
| 124 | 98 |
| 99 | |
|
| 84 |
| 86 |
| 111 |
| |
|
| 82 |
| 100 | 97 | 121 |
| |
|
| 92 |
| 88 |
|
| 77 | |
|
| 83 |
| 110 | 63 |
|
| |
|
| 91 |
| 91 | 95 |
| 107 | |
| PFLU3887 | 91 | 67 | 98 | 103 | 105 |
| |
| PFLU3887 | 90 |
| 109 | 103 | 112 | 103 | |
| PFLU5567 | 87 | 64 |
|
|
|
| |
| PFLU5567 | 93 | 103 |
|
|
|
| |
a: The strains were grown in deep-well plates containing the indicated media for four days before cell and alginate yield were measured. b: empty field denotes no supplement or complementing vector. c: Values are given as percentage of the control strain (SBW25 MS1 ΔalgC:: TnKB61). Actual values for the control strain were (growth [OD660]/alginate [g/L]): PIA: 0.492/0.33, DEF4 glycerol: 0.850/1.72, DEF4 fructose: 0.308/3.08. Growth above 125% and alginate production above 110% are marked using bold types, growth and alginate production between 10 and 50% are marked using italics, and growth and alginate production below 10% are written in bold italics
Effect of PhoBR disruptions on P. fluorescens growth and alginate biosynthesis
| Strain | Growth (OD600) | Alginate (g/l) |
|---|---|---|
| SBW25 | 2.5+/−0.24 | 4.3+/−0.89 |
| SBW25 | 2.7+/−0.33 | 3.6+/−0.36 |
| SBW25 | 1.4+/−0.12 | 0.0+/−0.0 |
| SBW25 | 2.4+/−0.09 | 4.0+/−0.24 |
| SBW25 | 2.1+/−0.10 | 4.3+/−0.66 |
| SBW25 | 1.5+/−0.20 | 1.2+/−0.56 |
| SBW25 | 2.0+/−0.13 | 5.5+/−0.12 |
a: The cells were grown for 72 h in shaking flasks using DEF3 medium with 20 g/l glycerol, 1 μM phosphate and 0.5 mM m-toluate. Average values from three independent experiments are shown
Bacterial strainsa and plasmids used in this study
| Strains | Description | Reference |
|---|---|---|
|
|
| [ |
|
| Non-mucoid | [ |
| SBW25MS1 | Derivative of SBW25 where the | This study |
| SBW25MS1 Δ | Derivative of SBW25 MS1 where | This study |
| SBW25 | Alginate-producing derivative of SBW25 encoding a defect MucA and where the expression of | H. Ertesvåg, unpublished |
| SBW25 | Derivative of SBW25 | This study |
| SBW25 | Derivative of SBW25 | This study |
|
| ||
| pKD20 | pUT based transposon vector containing | [ |
| pLitmus28Tc | High copy number cloning vector. Tcr, Apr | [ |
| pMG48 | RK2-based gene replacement vector. | [ |
| pMC1 | RK2-based gene replacement vector for replacing the DNA sequence upstream of | [ |
| pKB22 | Gene replacement vector for creating an | [ |
| pKB60 | Transposon vector. Contains the transposon TnKB60 with | [ |
| pYQ1 | pUT based transposon vector containing | [ |
| pEM1 | Derivative of pLitmus28Tc containing part of the transposon from pKD20. Apr | [ |
| pKB61 | Derivative of pKB60 where a 1.7 kb AvrII-NcoI DNA fragment encoding Kmr and most of XylS was exchanged with a 2.5 kb AvrII-NotI DNA fragment containing | This study |
| pMS9 | Derivative of pMC1 where a 0.7 kb SbfI-NotI DNA fragment containing a gene upstream of | This study |
| pMS2 | Derivative of pLitmus28Tc where the | This study |
| pMS10 | Derivative of pMS2 where a 0.5 kb BsiWI-EcoRI-fragment containing | This study |
| pMS11 | Derivative of pKD20 where a 3.7 kb BssHII-SfiI-fragment was exchanged with a 1.5 kb BssHII-SfiI-fragment containing | This study |
| pTK1 | Derivative of pEM1 in which a 2.2 kb PCR-amplified NdeI-NotI DNA fragment encoding | This study |
| pTK3 | Derivative of pTK1 in which an inserted 2.2 kb PCR-amplified NcoI-PspOMI DNA fragment from | This study |
| pTK4 | Derivative of pTK1 from which a 0.9 kb BstEII-BsaBI DNA fragment encoding most of phoR was deleted. Apr. | This study |
| pTK5 | Derivative of pKD20 in which a 1.5 kb NdeI-NotI PCR fragment from | This study |
| pTK6 | Derivative of pKD20 in which a 1.1 kb NcoI-NotI DNA fragment from pTK4 containing | This study |
| pTK7 | Derivative of pKD20 in which a 2.2 kb NdeI-NotI PCR fragment from | This study |
| pTK8 | Derivative of pTK1 from which a 0.3 kb BstEII DNA fragment was deleted, creating an in-frame deletion in | This study |
| pTK9 | Derivative of pMG48 in which a 3.0 kb NcoI-NotI DNA fragment from pTK8 was inserted, containing a deletion in | This study |
| pTK10 | Derivative of pMG48 in which a 3.1 kb NcoI-NotI DNA fragment from pTK3 was inserted, containing a deletion in | This study |
| pYQ1 trpF | Derivative of pYQ1 in which a 0.7 kb NdeI-NotI PCR fragment encoding TrpF was inserted. Amr. | This study |
| pYQ1 trpD | Derivative of pYQ1 in which a 1.1 kb NdeI-NotI PCR fragment encoding TrpD was inserted. Amr. | This study |
| pYQ1 trpDC | Derivative of pYQ1 in which a 1.9 kb NdeI-NotI PCR fragment encoding TrpDC was inserted. Amr. | This study |
| pYQ1 purH | Derivative of pYQ1 in which a 1.6 kb NdeI-NotI PCR fragment encoding PurH was inserted. Amr. | This study |
| pYQ1 purE | Derivative of pYQ1 in which a 0.5 kb NdeI-NotI PCR fragment encoding PurE was inserted. Amr. | This study |
| pYQ1 ilvD | Derivative of pYQ1 in which a 2.1 kb NdeI-NotI PCR fragment encoding IlvD was inserted. Amr. | This study |
| pYQ1 aceEI | Derivative of pYQ1 in which a 2.7 kb NdeI-NotI PCR fragment encoding AceE1 was inserted. Amr. | This study |
| pYQ1 PFLU3030 | Derivative of pYQ1 in which a 1.0 kb NdeI-NotI PCR fragment encoding PFLU3030 was inserted. Amr. | This study |
| pYQ1 PFLU3887 | Derivative of pYQ1 in which a 1.0 kb NdeI-NotI PCR fragment encoding PFLU3887 was inserted. Amr. | This study |
| pYQ1 PFLU5567 | Derivative of pYQ1 in which a 1.2 kb NdeI-NotI PCR fragment encoding PFLU5567 was inserted. Amr. | This study |
| pYQ1 dsbC | Derivative of pYQ1 in which a 0.9 kb NdeI-NotI PCR fragment encoding DsbC was inserted. Amr. | This study |
| pYQ1 sohB | Derivative of pYQ1 in which a 1.1 kb NdeI-NotI PCR fragment encoding SohB was inserted. Amr. | This study |
| pYQ1 nagZ | Derivative of pYQ1 in which a 1.1 kb NdeI-NotI PCR fragment encoding NagZ was inserted. Amr. | This study |
| pYQ1 anmK | Derivative of pYQ1 in which a 1.5 kb NdeI-NotI PCR fragment encoding AnmK was inserted. Amr. | This study |
| pYQ1 ispA | Derivative of pYQ1 in which a 0.9 kb NdeI-NotI PCR fragment encoding IspA was inserted. Amr. | This study |
| pYQ1 cbrB | Derivative of pYQ1 in which a 1.4 kb NdeI-NotI PCR fragment encoding CbrB was inserted. Amr. | This study |
a: Mutant strains complemented with transposons are not included in the Table